{"id":"NCT03629925","sponsor":"Innovent Biologics (Suzhou) Co. Ltd.","briefTitle":"Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC","officialTitle":"A Randomized, Double-Blind, Phase III Study to Compare the Efficacy and Safety of Sintilimab (IBI308) in Combination With Gemcitabine and Platinum-Based Chemotherapy vs. Placebo in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Treatment for Patients With Advanced or Metastatic Squamous Non-Small-Cell Lung Cancer (NSCLC) (ORIENT-12)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-09-28","primaryCompletion":"2020-03-25","completion":"2021-09-30","firstPosted":"2018-08-14","resultsPosted":"2021-04-01","lastUpdate":"2023-02-28"},"enrollment":357,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Squamous NSCLC"],"interventions":[{"type":"DRUG","name":"Sintilimab","otherNames":["IBI308"]},{"type":"DRUG","name":"Gemcitabine","otherNames":[]},{"type":"DRUG","name":"Cisplatin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Carboplatin","otherNames":[]}],"arms":[{"label":"Sintilimab+ gemcitabine plus platinum","type":"EXPERIMENTAL"},{"label":"Placebo+gemcitabine plus platinum","type":"PLACEBO_COMPARATOR"}],"summary":"Efficacy and Safety Evaluation of IBI308 in Patients with Advanced or Recurrent Squamous NSCLC","primaryOutcome":{"measure":"PFS(Progression Free Survival)","timeFrame":"Through Database Cutoff Date of 25 March 2020 (up to approximately 18 months)","effectByArm":[{"arm":"Sintilimab+ Gemcitabine Plus Platinum","deltaMin":5.5,"sd":null},{"arm":"Placebo+Gemcitabine Plus Platinum","deltaMin":4.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["China"]},"refs":{"pmids":["39395411","34048947"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":90,"n":179},"commonTop":["Anaemia","White blood cell count decreased","Neutrophil count decreased","Platelet count decreased","Nausea"]}}